Analyst Ratings for Arena Pharma (ARNA) [Sells]
ARNA Rating Summary
ARNA Price Target Summary
- Highest: $14.00 (Jefferies)
- Lowest: $6.00 (Credit Suisse)
- Average: $10.92
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$10.92 (+35.4%)
Avg. $ Target:
$10.92 (+35.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/6/2012 | Credit Suisse | New Coverage | Underperform (N/A) |
6.00 (N/A) |
9.16 | 8.06 | -12.01% | Details |
| 9/14/2010 | Barclays » Updated 3/14/2011 |
Downgrade | Underweight (N/A) |
N/A (N/A) |
6.79 | 8.06 | 18.7% | Details |
| 9/9/2010 | Hapoalim Securities | Downgrade | Sell (N/A) |
N/A (N/A) |
7.43 | 8.06 | 8.48% | Details |
| 9/8/2010 | BofA/Merrill Lynch | New Coverage | Underperform (N/A) |
N/A (N/A) |
7.34 | 8.06 | 9.81% | Details |
| 7/16/2010 | Rodman & Renshaw | Downgrade | Market Underperform (N/A) |
N/A (N/A) |
3.92 | 8.06 | 105.61% | Details |
